nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—Fluoxymesterone—breast cancer	0.258	1	CrCtD
Dexamethasone—CYP17A1—breast cancer	0.0362	0.18	CbGaD
Dexamethasone—NOS2—breast cancer	0.0295	0.147	CbGaD
Dexamethasone—PGR—breast cancer	0.0268	0.133	CbGaD
Dexamethasone—CYP1B1—breast cancer	0.0251	0.125	CbGaD
Dexamethasone—CYP19A1—breast cancer	0.0184	0.0915	CbGaD
Dexamethasone—ABCG2—breast cancer	0.0173	0.0859	CbGaD
Dexamethasone—CYP19A1—Exemestane—breast cancer	0.0149	0.0651	CbGbCtD
Dexamethasone—Testolactone—Exemestane—breast cancer	0.0137	0.0785	CrCrCtD
Dexamethasone—CYP1A1—breast cancer	0.0135	0.0673	CbGaD
Dexamethasone—CYP19A1—Letrozole—breast cancer	0.0127	0.0553	CbGbCtD
Dexamethasone—Prednisone—Exemestane—breast cancer	0.0123	0.0703	CrCrCtD
Dexamethasone—Loteprednol—Exemestane—breast cancer	0.0114	0.0653	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Exemestane—breast cancer	0.0114	0.0653	CrCrCtD
Dexamethasone—CYP19A1—Anastrozole—breast cancer	0.0113	0.0493	CbGbCtD
Dexamethasone—Methylprednisolone—Exemestane—breast cancer	0.0107	0.061	CrCrCtD
Dexamethasone—Prednisolone—Exemestane—breast cancer	0.0104	0.0597	CrCrCtD
Dexamethasone—CYP2D6—breast cancer	0.0101	0.0501	CbGaD
Dexamethasone—Testolactone—Fluoxymesterone—breast cancer	0.0095	0.0544	CrCrCtD
Dexamethasone—NR3C1—Fluoxymesterone—breast cancer	0.00939	0.041	CbGbCtD
Dexamethasone—Amcinonide—Fluoxymesterone—breast cancer	0.00874	0.05	CrCrCtD
Dexamethasone—CYP3A4—breast cancer	0.00864	0.043	CbGaD
Dexamethasone—Fludrocortisone—Fluoxymesterone—breast cancer	0.00851	0.0487	CrCrCtD
Dexamethasone—Clobetasol propionate—Fluoxymesterone—breast cancer	0.00851	0.0487	CrCrCtD
Dexamethasone—PTGS2—breast cancer	0.00846	0.0421	CbGaD
Dexamethasone—NOS2—Doxorubicin—breast cancer	0.0082	0.0357	CbGbCtD
Dexamethasone—Desoximetasone—Fluoxymesterone—breast cancer	0.00809	0.0463	CrCrCtD
Dexamethasone—CYP2A6—Letrozole—breast cancer	0.00804	0.0351	CbGbCtD
Dexamethasone—Mometasone—Fluoxymesterone—breast cancer	0.0079	0.0453	CrCrCtD
Dexamethasone—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0079	0.0453	CrCrCtD
Dexamethasone—Fluorometholone—Fluoxymesterone—breast cancer	0.0079	0.0453	CrCrCtD
Dexamethasone—Loteprednol—Fluoxymesterone—breast cancer	0.0079	0.0453	CrCrCtD
Dexamethasone—Triamcinolone—Fluoxymesterone—breast cancer	0.0079	0.0453	CrCrCtD
Dexamethasone—Betamethasone—Fluoxymesterone—breast cancer	0.00772	0.0442	CrCrCtD
Dexamethasone—Prednisolone—Fluoxymesterone—breast cancer	0.00723	0.0414	CrCrCtD
Dexamethasone—ABCB1—breast cancer	0.00719	0.0358	CbGaD
Dexamethasone—Hydrocortisone—Fluoxymesterone—breast cancer	0.00694	0.0397	CrCrCtD
Dexamethasone—SLCO1A2—Chlorambucil—breast cancer	0.00671	0.0292	CbGbCtD
Dexamethasone—CYP19A1—Raloxifene—breast cancer	0.00572	0.0249	CbGbCtD
Dexamethasone—CYP1A1—Toremifene—breast cancer	0.0056	0.0244	CbGbCtD
Dexamethasone—CYP1B1—Tamoxifen—breast cancer	0.00466	0.0203	CbGbCtD
Dexamethasone—ABCB11—Tamoxifen—breast cancer	0.00466	0.0203	CbGbCtD
Dexamethasone—CYP1B1—Mitoxantrone—breast cancer	0.00455	0.0198	CbGbCtD
Dexamethasone—CYP19A1—Tamoxifen—breast cancer	0.00378	0.0165	CbGbCtD
Dexamethasone—CYP1B1—Paclitaxel—breast cancer	0.00363	0.0158	CbGbCtD
Dexamethasone—ABCB11—Paclitaxel—breast cancer	0.00363	0.0158	CbGbCtD
Dexamethasone—CYP2B6—Thiotepa—breast cancer	0.00354	0.0154	CbGbCtD
Dexamethasone—ABCB11—Vinblastine—breast cancer	0.00318	0.0139	CbGbCtD
Dexamethasone—CYP19A1—Paclitaxel—breast cancer	0.00294	0.0128	CbGbCtD
Dexamethasone—CYP1B1—Docetaxel—breast cancer	0.00262	0.0114	CbGbCtD
Dexamethasone—CYP2C9—Anastrozole—breast cancer	0.00246	0.0107	CbGbCtD
Dexamethasone—CYP3A5—Lapatinib—breast cancer	0.00245	0.0107	CbGbCtD
Dexamethasone—ABCC2—Tamoxifen—breast cancer	0.00245	0.0107	CbGbCtD
Dexamethasone—CYP2A6—Tamoxifen—breast cancer	0.00239	0.0104	CbGbCtD
Dexamethasone—CYP2B6—Raloxifene—breast cancer	0.00236	0.0103	CbGbCtD
Dexamethasone—CYP2C8—Lapatinib—breast cancer	0.00236	0.0103	CbGbCtD
Dexamethasone—ABCG2—Tamoxifen—breast cancer	0.00222	0.00966	CbGbCtD
Dexamethasone—ABCB1—Toremifene—breast cancer	0.00219	0.00954	CbGbCtD
Dexamethasone—CYP11A1—corpus luteum—breast cancer	0.00217	0.0934	CbGeAlD
Dexamethasone—ABCG2—Mitoxantrone—breast cancer	0.00216	0.00942	CbGbCtD
Dexamethasone—CYP1A1—Tamoxifen—breast cancer	0.00205	0.00892	CbGbCtD
Dexamethasone—CYP2C19—Lapatinib—breast cancer	0.00198	0.00862	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—breast cancer	0.00196	0.00853	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—breast cancer	0.00196	0.00853	CbGbCtD
Dexamethasone—ABCC2—Paclitaxel—breast cancer	0.00191	0.00832	CbGbCtD
Dexamethasone—CYP3A4—Exemestane—breast cancer	0.00189	0.00824	CbGbCtD
Dexamethasone—ABCC2—Irinotecan—breast cancer	0.00188	0.00821	CbGbCtD
Dexamethasone—CYP2C9—Idarubicin—breast cancer	0.00187	0.00814	CbGbCtD
Dexamethasone—ABCC2—Carboplatin—breast cancer	0.0018	0.00783	CbGbCtD
Dexamethasone—CYP2C8—Raloxifene—breast cancer	0.00179	0.00779	CbGbCtD
Dexamethasone—CYP2A6—Fluorouracil—breast cancer	0.00176	0.00769	CbGbCtD
Dexamethasone—ABCG2—Paclitaxel—breast cancer	0.00172	0.00752	CbGbCtD
Dexamethasone—CYP2D6—Idarubicin—breast cancer	0.00171	0.00745	CbGbCtD
Dexamethasone—ABCG2—Irinotecan—breast cancer	0.0017	0.00742	CbGbCtD
Dexamethasone—ABCC2—Vinblastine—breast cancer	0.00167	0.0073	CbGbCtD
Dexamethasone—CYP3A7—Tamoxifen—breast cancer	0.00164	0.00714	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00164	0.00714	CbGbCtD
Dexamethasone—ABCG2—Fluorouracil—breast cancer	0.00163	0.00712	CbGbCtD
Dexamethasone—ABCG2—Carboplatin—breast cancer	0.00162	0.00708	CbGbCtD
Dexamethasone—CYP3A4—Letrozole—breast cancer	0.00161	0.00701	CbGbCtD
Dexamethasone—ABCB1—Lapatinib—breast cancer	0.0016	0.00696	CbGbCtD
Dexamethasone—CYP2E1—Tamoxifen—breast cancer	0.00158	0.00689	CbGbCtD
Dexamethasone—PGR—corpus luteum—breast cancer	0.00156	0.0674	CbGeAlD
Dexamethasone—CYP2B6—Tamoxifen—breast cancer	0.00156	0.0068	CbGbCtD
Dexamethasone—CYP2E1—Mitoxantrone—breast cancer	0.00154	0.00672	CbGbCtD
Dexamethasone—CYP3A4—Anastrozole—breast cancer	0.00143	0.00625	CbGbCtD
Dexamethasone—CYP19A1—corpus luteum—breast cancer	0.00141	0.0607	CbGeAlD
Dexamethasone—ABCC2—Docetaxel—breast cancer	0.00138	0.00601	CbGbCtD
Dexamethasone—CYP3A4—Toremifene—breast cancer	0.00131	0.00571	CbGbCtD
Dexamethasone—CYP3A7—Paclitaxel—breast cancer	0.00127	0.00555	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00127	0.00555	CbGbCtD
Dexamethasone—CYP3A7—Irinotecan—breast cancer	0.00126	0.00548	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00126	0.00548	CbGbCtD
Dexamethasone—ABCG2—Docetaxel—breast cancer	0.00125	0.00544	CbGbCtD
Dexamethasone—CYP3A5—Tamoxifen—breast cancer	0.00123	0.00535	CbGbCtD
Dexamethasone—CYP3A4—Fulvestrant—breast cancer	0.00122	0.00531	CbGbCtD
Dexamethasone—SLCO1A2—Methotrexate—breast cancer	0.0012	0.00524	CbGbCtD
Dexamethasone—CYP2B6—Irinotecan—breast cancer	0.0012	0.00522	CbGbCtD
Dexamethasone—CYP2C8—Tamoxifen—breast cancer	0.00118	0.00515	CbGbCtD
Dexamethasone—CYP3A4—Thiotepa—breast cancer	0.00109	0.00473	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—breast cancer	0.00103	0.00448	CbGbCtD
Dexamethasone—CYP2C9—Capecitabine—breast cancer	0.00102	0.00446	CbGbCtD
Dexamethasone—ABCC2—Methotrexate—breast cancer	0.000996	0.00434	CbGbCtD
Dexamethasone—CYP3A4—Ixabepilone—breast cancer	0.000993	0.00433	CbGbCtD
Dexamethasone—CYP2C19—Tamoxifen—breast cancer	0.00099	0.00432	CbGbCtD
Dexamethasone—CYP3A4—Lapatinib—breast cancer	0.000956	0.00417	CbGbCtD
Dexamethasone—CYP3A5—Paclitaxel—breast cancer	0.000956	0.00417	CbGbCtD
Dexamethasone—CYP3A5—Irinotecan—breast cancer	0.000943	0.00411	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—breast cancer	0.00093	0.00405	CbGbCtD
Dexamethasone—CYP3A7—Docetaxel—breast cancer	0.000921	0.00402	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.000921	0.00402	CbGbCtD
Dexamethasone—CYP2C8—Paclitaxel—breast cancer	0.000919	0.00401	CbGbCtD
Dexamethasone—ABCG2—Methotrexate—breast cancer	0.000901	0.00393	CbGbCtD
Dexamethasone—ABCB1—Vinorelbine—breast cancer	0.000885	0.00386	CbGbCtD
Dexamethasone—CYP2C8—Fluorouracil—breast cancer	0.00087	0.00379	CbGbCtD
Dexamethasone—CYP2D6—Vinorelbine—breast cancer	0.000834	0.00364	CbGbCtD
Dexamethasone—CYP2C9—Tamoxifen—breast cancer	0.000823	0.00359	CbGbCtD
Dexamethasone—ABCB1—Tamoxifen—breast cancer	0.000799	0.00348	CbGbCtD
Dexamethasone—ABCB1—Mitoxantrone—breast cancer	0.000779	0.0034	CbGbCtD
Dexamethasone—CYP2D6—Tamoxifen—breast cancer	0.000753	0.00328	CbGbCtD
Dexamethasone—CYP3A4—Raloxifene—breast cancer	0.000725	0.00316	CbGbCtD
Dexamethasone—CYP3A5—Docetaxel—breast cancer	0.000691	0.00301	CbGbCtD
Dexamethasone—ABCB1—Gemcitabine—breast cancer	0.000688	0.003	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—breast cancer	0.000654	0.00285	CbGbCtD
Dexamethasone—CYP2C9—Paclitaxel—breast cancer	0.000641	0.00279	CbGbCtD
Dexamethasone—ABCB1—Paclitaxel—breast cancer	0.000622	0.00271	CbGbCtD
Dexamethasone—ABCB1—Irinotecan—breast cancer	0.000614	0.00268	CbGbCtD
Dexamethasone—CYP2C9—Fluorouracil—breast cancer	0.000607	0.00265	CbGbCtD
Dexamethasone—NOS2—adrenal gland—breast cancer	0.000559	0.0241	CbGeAlD
Dexamethasone—ABCB1—Vinblastine—breast cancer	0.000546	0.00238	CbGbCtD
Dexamethasone—CYP3A4—Vinorelbine—breast cancer	0.00053	0.00231	CbGbCtD
Dexamethasone—CYP2D6—Vinblastine—breast cancer	0.000514	0.00224	CbGbCtD
Dexamethasone—CYP3A4—Tamoxifen—breast cancer	0.000479	0.00209	CbGbCtD
Dexamethasone—CYP3A4—Mitoxantrone—breast cancer	0.000467	0.00204	CbGbCtD
Dexamethasone—ABCB1—Docetaxel—breast cancer	0.00045	0.00196	CbGbCtD
Dexamethasone—ANXA1—mammary gland—breast cancer	0.000403	0.0174	CbGeAlD
Dexamethasone—CYP3A4—Paclitaxel—breast cancer	0.000373	0.00162	CbGbCtD
Dexamethasone—CYP3A4—Irinotecan—breast cancer	0.000368	0.0016	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—breast cancer	0.000335	0.00146	CbGbCtD
Dexamethasone—NR0B1—pituitary gland—breast cancer	0.000334	0.0144	CbGeAlD
Dexamethasone—ANXA1—nipple—breast cancer	0.000333	0.0144	CbGeAlD
Dexamethasone—CYP3A4—Vinblastine—breast cancer	0.000327	0.00143	CbGbCtD
Dexamethasone—ABCB1—Methotrexate—breast cancer	0.000325	0.00142	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—breast cancer	0.000316	0.00138	CbGbCtD
Dexamethasone—CYP3A43—endocrine gland—breast cancer	0.000312	0.0135	CbGeAlD
Dexamethasone—NR0B1—female reproductive system—breast cancer	0.000306	0.0132	CbGeAlD
Dexamethasone—NR0B1—adrenal gland—breast cancer	0.000298	0.0129	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—breast cancer	0.000293	0.0126	CbGeAlD
Dexamethasone—Fluoxymesterone—PRLR—breast cancer	0.000292	0.23	CrCbGaD
Dexamethasone—NR0B1—female gonad—breast cancer	0.000278	0.012	CbGeAlD
Dexamethasone—ANXA1—embryo—breast cancer	0.000275	0.0118	CbGeAlD
Dexamethasone—CYP3A4—Docetaxel—breast cancer	0.000269	0.00117	CbGbCtD
Dexamethasone—NR0B1—endocrine gland—breast cancer	0.000259	0.0112	CbGeAlD
Dexamethasone—PGR—mammary gland—breast cancer	0.000242	0.0104	CbGeAlD
Dexamethasone—PLA2G1B—pituitary gland—breast cancer	0.000238	0.0103	CbGeAlD
Dexamethasone—ANXA1—epithelium—breast cancer	0.000224	0.00967	CbGeAlD
Dexamethasone—CYP4A11—endocrine gland—breast cancer	0.000222	0.00959	CbGeAlD
Dexamethasone—PLA2G1B—female reproductive system—breast cancer	0.000218	0.00939	CbGeAlD
Dexamethasone—NR3C2—nipple—breast cancer	0.000216	0.0093	CbGeAlD
Dexamethasone—ANXA1—skin of body—breast cancer	0.000213	0.00919	CbGeAlD
Dexamethasone—PLA2G1B—adrenal gland—breast cancer	0.000213	0.00916	CbGeAlD
Dexamethasone—CYP1B1—mammary gland—breast cancer	0.000204	0.00879	CbGeAlD
Dexamethasone—ANXA1—endometrium—breast cancer	0.000201	0.00867	CbGeAlD
Dexamethasone—CYP3A4—Doxorubicin—breast cancer	0.000201	0.000876	CbGbCtD
Dexamethasone—PGR—nipple—breast cancer	0.0002	0.00864	CbGeAlD
Dexamethasone—PLA2G1B—female gonad—breast cancer	0.000198	0.00854	CbGeAlD
Dexamethasone—ANXA1—uterus—breast cancer	0.000185	0.00799	CbGeAlD
Dexamethasone—PLA2G1B—endocrine gland—breast cancer	0.000184	0.00795	CbGeAlD
Dexamethasone—ANXA1—pituitary gland—breast cancer	0.000182	0.00784	CbGeAlD
Dexamethasone—ANXA1—adipose tissue—breast cancer	0.000181	0.00781	CbGeAlD
Dexamethasone—ANXA1—female reproductive system—breast cancer	0.000167	0.00718	CbGeAlD
Dexamethasone—ANXA1—adrenal gland—breast cancer	0.000163	0.00701	CbGeAlD
Dexamethasone—ANXA1—bone marrow—breast cancer	0.000157	0.00678	CbGeAlD
Dexamethasone—CYP2C8—mammary gland—breast cancer	0.000156	0.00673	CbGeAlD
Dexamethasone—ANXA1—female gonad—breast cancer	0.000152	0.00653	CbGeAlD
Dexamethasone—CYP11A1—adipose tissue—breast cancer	0.000151	0.00651	CbGeAlD
Dexamethasone—CYP17A1—female reproductive system—breast cancer	0.000149	0.00644	CbGeAlD
Dexamethasone—CYP17A1—adrenal gland—breast cancer	0.000146	0.00628	CbGeAlD
Dexamethasone—ABCB11—endocrine gland—breast cancer	0.000143	0.00618	CbGeAlD
Dexamethasone—ANXA1—endocrine gland—breast cancer	0.000141	0.00608	CbGeAlD
Dexamethasone—CYP3A7—endocrine gland—breast cancer	0.00014	0.00604	CbGeAlD
Dexamethasone—CYP11A1—female reproductive system—breast cancer	0.000139	0.00599	CbGeAlD
Dexamethasone—CYP2C9—mammary gland—breast cancer	0.000139	0.00598	CbGeAlD
Dexamethasone—CYP17A1—female gonad—breast cancer	0.000136	0.00586	CbGeAlD
Dexamethasone—CYP11A1—adrenal gland—breast cancer	0.000136	0.00584	CbGeAlD
Dexamethasone—PGR—epithelium—breast cancer	0.000135	0.00582	CbGeAlD
Dexamethasone—NR3C2—endometrium—breast cancer	0.00013	0.00561	CbGeAlD
Dexamethasone—CYP11A1—female gonad—breast cancer	0.000126	0.00545	CbGeAlD
Dexamethasone—CYP17A1—endocrine gland—breast cancer	0.000126	0.00545	CbGeAlD
Dexamethasone—CYP2A6—adipose tissue—breast cancer	0.000125	0.0054	CbGeAlD
Dexamethasone—PGR—endometrium—breast cancer	0.000121	0.00522	CbGeAlD
Dexamethasone—NR3C2—uterus—breast cancer	0.00012	0.00517	CbGeAlD
Dexamethasone—CYP1A1—nipple—breast cancer	0.000119	0.00514	CbGeAlD
Dexamethasone—NR3C2—pituitary gland—breast cancer	0.000118	0.00508	CbGeAlD
Dexamethasone—CYP11A1—endocrine gland—breast cancer	0.000118	0.00507	CbGeAlD
Dexamethasone—NR3C2—adipose tissue—breast cancer	0.000117	0.00506	CbGeAlD
Dexamethasone—NR3C1—nipple—breast cancer	0.000116	0.00499	CbGeAlD
Dexamethasone—PGR—uterus—breast cancer	0.000112	0.00481	CbGeAlD
Dexamethasone—PGR—pituitary gland—breast cancer	0.00011	0.00472	CbGeAlD
Dexamethasone—PGR—adipose tissue—breast cancer	0.000109	0.0047	CbGeAlD
Dexamethasone—CYP19A1—endometrium—breast cancer	0.000109	0.0047	CbGeAlD
Dexamethasone—CYP1B1—skin of body—breast cancer	0.000108	0.00466	CbGeAlD
Dexamethasone—NR3C2—female reproductive system—breast cancer	0.000108	0.00465	CbGeAlD
Dexamethasone—NR3C2—adrenal gland—breast cancer	0.000105	0.00454	CbGeAlD
Dexamethasone—CYP19A1—uterus—breast cancer	0.0001	0.00433	CbGeAlD
Dexamethasone—PGR—female reproductive system—breast cancer	0.0001	0.00432	CbGeAlD
Dexamethasone—CYP19A1—adipose tissue—breast cancer	9.81e-05	0.00423	CbGeAlD
Dexamethasone—NR3C2—female gonad—breast cancer	9.81e-05	0.00423	CbGeAlD
Dexamethasone—PGR—adrenal gland—breast cancer	9.78e-05	0.00422	CbGeAlD
Dexamethasone—ANXA1—lymph node—breast cancer	9.74e-05	0.0042	CbGeAlD
Dexamethasone—Fluocinolone Acetonide—PLA2G4A—breast cancer	9.71e-05	0.0764	CrCbGaD
Dexamethasone—NR3C1—embryo—breast cancer	9.54e-05	0.00411	CbGeAlD
Dexamethasone—CYP1B1—uterus—breast cancer	9.38e-05	0.00405	CbGeAlD
Dexamethasone—CYP1B1—pituitary gland—breast cancer	9.21e-05	0.00397	CbGeAlD
Dexamethasone—CYP1B1—adipose tissue—breast cancer	9.18e-05	0.00396	CbGeAlD
Dexamethasone—NR3C2—endocrine gland—breast cancer	9.13e-05	0.00394	CbGeAlD
Dexamethasone—PGR—female gonad—breast cancer	9.12e-05	0.00393	CbGeAlD
Dexamethasone—CYP19A1—female reproductive system—breast cancer	9.02e-05	0.00389	CbGeAlD
Dexamethasone—CYP19A1—adrenal gland—breast cancer	8.8e-05	0.0038	CbGeAlD
Dexamethasone—CYP17A1—lymph node—breast cancer	8.73e-05	0.00376	CbGeAlD
Dexamethasone—ABCC2—female reproductive system—breast cancer	8.61e-05	0.00371	CbGeAlD
Dexamethasone—PGR—endocrine gland—breast cancer	8.48e-05	0.00366	CbGeAlD
Dexamethasone—CYP1B1—female reproductive system—breast cancer	8.43e-05	0.00364	CbGeAlD
Dexamethasone—ABCC2—adrenal gland—breast cancer	8.4e-05	0.00362	CbGeAlD
Dexamethasone—PTGS2—embryo—breast cancer	8.26e-05	0.00356	CbGeAlD
Dexamethasone—CYP1B1—adrenal gland—breast cancer	8.23e-05	0.00355	CbGeAlD
Dexamethasone—CYP19A1—female gonad—breast cancer	8.21e-05	0.00354	CbGeAlD
Dexamethasone—CYP11A1—lymph node—breast cancer	8.12e-05	0.0035	CbGeAlD
Dexamethasone—CYP1A1—epithelium—breast cancer	8.03e-05	0.00346	CbGeAlD
Dexamethasone—SLCO1A2—endocrine gland—breast cancer	7.82e-05	0.00337	CbGeAlD
Dexamethasone—CYP2C8—endometrium—breast cancer	7.8e-05	0.00336	CbGeAlD
Dexamethasone—NR3C1—epithelium—breast cancer	7.79e-05	0.00336	CbGeAlD
Dexamethasone—CYP1B1—female gonad—breast cancer	7.67e-05	0.00331	CbGeAlD
Dexamethasone—CYP19A1—endocrine gland—breast cancer	7.63e-05	0.00329	CbGeAlD
Dexamethasone—CYP1A1—skin of body—breast cancer	7.63e-05	0.00329	CbGeAlD
Dexamethasone—ABCG2—endometrium—breast cancer	7.58e-05	0.00327	CbGeAlD
Dexamethasone—CYP2B6—skin of body—breast cancer	7.42e-05	0.0032	CbGeAlD
Dexamethasone—NR3C1—skin of body—breast cancer	7.41e-05	0.00319	CbGeAlD
Dexamethasone—ABCC2—endocrine gland—breast cancer	7.29e-05	0.00314	CbGeAlD
Dexamethasone—CYP1B1—endocrine gland—breast cancer	7.14e-05	0.00308	CbGeAlD
Dexamethasone—CYP2C8—pituitary gland—breast cancer	7.06e-05	0.00304	CbGeAlD
Dexamethasone—Testolactone—CYP19A1—breast cancer	7.03e-05	0.0553	CrCbGaD
Dexamethasone—ABCG2—uterus—breast cancer	6.99e-05	0.00301	CbGeAlD
Dexamethasone—NR3C1—endometrium—breast cancer	6.98e-05	0.00301	CbGeAlD
Dexamethasone—ABCG2—pituitary gland—breast cancer	6.86e-05	0.00296	CbGeAlD
Dexamethasone—ABCG2—adipose tissue—breast cancer	6.83e-05	0.00295	CbGeAlD
Dexamethasone—PTGS2—epithelium—breast cancer	6.74e-05	0.00291	CbGeAlD
Dexamethasone—Fluticasone Propionate—PLA2G4A—breast cancer	6.64e-05	0.0522	CrCbGaD
Dexamethasone—CYP1A1—uterus—breast cancer	6.63e-05	0.00286	CbGeAlD
Dexamethasone—CYP1A1—adipose tissue—breast cancer	6.49e-05	0.0028	CbGeAlD
Dexamethasone—CYP2C8—female reproductive system—breast cancer	6.46e-05	0.00279	CbGeAlD
Dexamethasone—NR3C1—uterus—breast cancer	6.43e-05	0.00277	CbGeAlD
Dexamethasone—PTGS2—skin of body—breast cancer	6.41e-05	0.00276	CbGeAlD
Dexamethasone—CYP3A5—adipose tissue—breast cancer	6.34e-05	0.00273	CbGeAlD
Dexamethasone—NR3C1—pituitary gland—breast cancer	6.32e-05	0.00272	CbGeAlD
Dexamethasone—NR3C2—lymph node—breast cancer	6.31e-05	0.00272	CbGeAlD
Dexamethasone—NR3C1—adipose tissue—breast cancer	6.29e-05	0.00271	CbGeAlD
Dexamethasone—CYP2C19—endocrine gland—breast cancer	6.26e-05	0.0027	CbGeAlD
Dexamethasone—ABCG2—adrenal gland—breast cancer	6.13e-05	0.00264	CbGeAlD
Dexamethasone—PTGS2—endometrium—breast cancer	6.04e-05	0.00261	CbGeAlD
Dexamethasone—CYP1A1—female reproductive system—breast cancer	5.96e-05	0.00257	CbGeAlD
Dexamethasone—ABCG2—bone marrow—breast cancer	5.93e-05	0.00256	CbGeAlD
Dexamethasone—PGR—lymph node—breast cancer	5.86e-05	0.00253	CbGeAlD
Dexamethasone—CYP2B6—female reproductive system—breast cancer	5.79e-05	0.0025	CbGeAlD
Dexamethasone—NR3C1—female reproductive system—breast cancer	5.78e-05	0.00249	CbGeAlD
Dexamethasone—CYP2C9—female reproductive system—breast cancer	5.74e-05	0.00247	CbGeAlD
Dexamethasone—ABCG2—female gonad—breast cancer	5.71e-05	0.00246	CbGeAlD
Dexamethasone—CYP2B6—adrenal gland—breast cancer	5.65e-05	0.00244	CbGeAlD
Dexamethasone—NR3C1—adrenal gland—breast cancer	5.64e-05	0.00243	CbGeAlD
Dexamethasone—PTGS2—uterus—breast cancer	5.57e-05	0.0024	CbGeAlD
Dexamethasone—PTGS2—pituitary gland—breast cancer	5.47e-05	0.00236	CbGeAlD
Dexamethasone—CYP2C8—endocrine gland—breast cancer	5.47e-05	0.00236	CbGeAlD
Dexamethasone—NR3C1—bone marrow—breast cancer	5.46e-05	0.00235	CbGeAlD
Dexamethasone—PTGS2—adipose tissue—breast cancer	5.45e-05	0.00235	CbGeAlD
Dexamethasone—CYP2E1—female reproductive system—breast cancer	5.44e-05	0.00234	CbGeAlD
Dexamethasone—CYP1A1—female gonad—breast cancer	5.42e-05	0.00234	CbGeAlD
Dexamethasone—CYP2E1—adrenal gland—breast cancer	5.31e-05	0.00229	CbGeAlD
Dexamethasone—CYP3A5—female gonad—breast cancer	5.3e-05	0.00229	CbGeAlD
Dexamethasone—CYP19A1—lymph node—breast cancer	5.28e-05	0.00228	CbGeAlD
Dexamethasone—NR3C1—female gonad—breast cancer	5.26e-05	0.00227	CbGeAlD
Dexamethasone—Fludrocortisone—AR—breast cancer	5.12e-05	0.0403	CrCbGaD
Dexamethasone—ABCB1—embryo—breast cancer	5.11e-05	0.0022	CbGeAlD
Dexamethasone—CYP1A1—endocrine gland—breast cancer	5.05e-05	0.00218	CbGeAlD
Dexamethasone—ABCC2—lymph node—breast cancer	5.04e-05	0.00217	CbGeAlD
Dexamethasone—PTGS2—female reproductive system—breast cancer	5.01e-05	0.00216	CbGeAlD
Dexamethasone—CYP1B1—lymph node—breast cancer	4.93e-05	0.00213	CbGeAlD
Dexamethasone—CYP3A5—endocrine gland—breast cancer	4.93e-05	0.00213	CbGeAlD
Dexamethasone—CYP2B6—endocrine gland—breast cancer	4.9e-05	0.00211	CbGeAlD
Dexamethasone—NR3C1—endocrine gland—breast cancer	4.89e-05	0.00211	CbGeAlD
Dexamethasone—PTGS2—adrenal gland—breast cancer	4.89e-05	0.00211	CbGeAlD
Dexamethasone—CYP2C9—endocrine gland—breast cancer	4.85e-05	0.00209	CbGeAlD
Dexamethasone—Fluoxymesterone—SHBG—breast cancer	4.83e-05	0.0379	CrCbGaD
Dexamethasone—PTGS2—bone marrow—breast cancer	4.73e-05	0.00204	CbGeAlD
Dexamethasone—CYP2E1—endocrine gland—breast cancer	4.6e-05	0.00198	CbGeAlD
Dexamethasone—PTGS2—female gonad—breast cancer	4.56e-05	0.00196	CbGeAlD
Dexamethasone—Fluticasone Propionate—PGR—breast cancer	4.39e-05	0.0345	CrCbGaD
Dexamethasone—CYP3A4—female reproductive system—breast cancer	4.37e-05	0.00189	CbGeAlD
Dexamethasone—CYP2D6—female reproductive system—breast cancer	4.3e-05	0.00186	CbGeAlD
Dexamethasone—PTGS2—endocrine gland—breast cancer	4.24e-05	0.00183	CbGeAlD
Dexamethasone—Fluoxymesterone—AR—breast cancer	4.23e-05	0.0333	CrCbGaD
Dexamethasone—ABCB1—epithelium—breast cancer	4.17e-05	0.0018	CbGeAlD
Dexamethasone—Betamethasone—PGR—breast cancer	4.02e-05	0.0316	CrCbGaD
Dexamethasone—CYP2D6—female gonad—breast cancer	3.92e-05	0.00169	CbGeAlD
Dexamethasone—ABCB1—endometrium—breast cancer	3.74e-05	0.00161	CbGeAlD
Dexamethasone—CYP3A4—endocrine gland—breast cancer	3.7e-05	0.0016	CbGeAlD
Dexamethasone—ABCG2—lymph node—breast cancer	3.67e-05	0.00158	CbGeAlD
Dexamethasone—CYP2D6—endocrine gland—breast cancer	3.64e-05	0.00157	CbGeAlD
Dexamethasone—CYP1A1—lymph node—breast cancer	3.49e-05	0.0015	CbGeAlD
Dexamethasone—ABCB1—uterus—breast cancer	3.44e-05	0.00149	CbGeAlD
Dexamethasone—NR3C1—lymph node—breast cancer	3.38e-05	0.00146	CbGeAlD
Dexamethasone—ABCB1—pituitary gland—breast cancer	3.38e-05	0.00146	CbGeAlD
Dexamethasone—ABCB1—adipose tissue—breast cancer	3.37e-05	0.00145	CbGeAlD
Dexamethasone—Triamcinolone—BCHE—breast cancer	3.36e-05	0.0264	CrCbGaD
Dexamethasone—Fluoxymesterone—ESR1—breast cancer	3.26e-05	0.0256	CrCbGaD
Dexamethasone—Clobetasol propionate—CYP1A1—breast cancer	3.16e-05	0.0248	CrCbGaD
Dexamethasone—ABCB1—female reproductive system—breast cancer	3.1e-05	0.00134	CbGeAlD
Dexamethasone—ABCB1—adrenal gland—breast cancer	3.02e-05	0.0013	CbGeAlD
Dexamethasone—Hydrocortisone—SHBG—breast cancer	2.94e-05	0.0231	CrCbGaD
Dexamethasone—PTGS2—lymph node—breast cancer	2.93e-05	0.00126	CbGeAlD
Dexamethasone—ABCB1—bone marrow—breast cancer	2.92e-05	0.00126	CbGeAlD
Dexamethasone—ABCB1—female gonad—breast cancer	2.82e-05	0.00122	CbGeAlD
Dexamethasone—Betamethasone—CYP19A1—breast cancer	2.76e-05	0.0217	CrCbGaD
Dexamethasone—ABCB1—endocrine gland—breast cancer	2.62e-05	0.00113	CbGeAlD
Dexamethasone—Budesonide—CYP3A4—breast cancer	2.4e-05	0.0189	CrCbGaD
Dexamethasone—Fluticasone furoate—CYP3A4—breast cancer	2.35e-05	0.0185	CrCbGaD
Dexamethasone—Alclometasone—CYP3A4—breast cancer	2.07e-05	0.0163	CrCbGaD
Dexamethasone—Hydrocortisone—ABCG2—breast cancer	2.02e-05	0.0159	CrCbGaD
Dexamethasone—Flunisolide—CYP3A4—breast cancer	2.01e-05	0.0158	CrCbGaD
Dexamethasone—Paramethasone—CYP3A4—breast cancer	1.99e-05	0.0156	CrCbGaD
Dexamethasone—Fluticasone furoate—ABCB1—breast cancer	1.96e-05	0.0154	CrCbGaD
Dexamethasone—Fluorometholone—CYP3A4—breast cancer	1.94e-05	0.0153	CrCbGaD
Dexamethasone—Methylprednisolone—CYP3A4—breast cancer	1.88e-05	0.0148	CrCbGaD
Dexamethasone—ABCB1—lymph node—breast cancer	1.81e-05	0.000781	CbGeAlD
Dexamethasone—Triamcinolone—CYP3A4—breast cancer	1.58e-05	0.0124	CrCbGaD
Dexamethasone—Methylprednisolone—ABCB1—breast cancer	1.56e-05	0.0123	CrCbGaD
Dexamethasone—Triamcinolone—PTGS2—breast cancer	1.55e-05	0.0122	CrCbGaD
Dexamethasone—Prednisone—CYP3A4—breast cancer	1.44e-05	0.0113	CrCbGaD
Dexamethasone—Fluticasone Propionate—CYP3A4—breast cancer	1.41e-05	0.0111	CrCbGaD
Dexamethasone—Prednisolone—CYP3A4—breast cancer	1.32e-05	0.0104	CrCbGaD
Dexamethasone—Betamethasone—CYP3A4—breast cancer	1.3e-05	0.0102	CrCbGaD
Dexamethasone—Betamethasone—PTGS2—breast cancer	1.27e-05	0.00998	CrCbGaD
Dexamethasone—Prednisone—ALB—breast cancer	1.25e-05	0.00984	CrCbGaD
Dexamethasone—Prednisone—ABCB1—breast cancer	1.19e-05	0.00939	CrCbGaD
Dexamethasone—Weight increased—Doxorubicin—breast cancer	1.18e-05	0.000201	CcSEcCtD
Dexamethasone—Discomfort—Capecitabine—breast cancer	1.18e-05	0.000201	CcSEcCtD
Dexamethasone—Pruritus—Gemcitabine—breast cancer	1.18e-05	0.000201	CcSEcCtD
Dexamethasone—Nausea—Thiotepa—breast cancer	1.17e-05	0.000201	CcSEcCtD
Dexamethasone—Infection—Docetaxel—breast cancer	1.17e-05	0.0002	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—breast cancer	1.17e-05	0.0002	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—breast cancer	1.17e-05	0.0002	CcSEcCtD
Dexamethasone—Diarrhoea—Mitoxantrone—breast cancer	1.17e-05	0.0002	CcSEcCtD
Dexamethasone—Diarrhoea—Irinotecan—breast cancer	1.17e-05	0.0002	CcSEcCtD
Dexamethasone—Shock—Docetaxel—breast cancer	1.16e-05	0.000198	CcSEcCtD
Dexamethasone—Nervous system disorder—Docetaxel—breast cancer	1.16e-05	0.000198	CcSEcCtD
Dexamethasone—Pruritus—Fluorouracil—breast cancer	1.16e-05	0.000198	CcSEcCtD
Dexamethasone—Thrombocytopenia—Docetaxel—breast cancer	1.16e-05	0.000197	CcSEcCtD
Dexamethasone—Visual impairment—Methotrexate—breast cancer	1.15e-05	0.000197	CcSEcCtD
Dexamethasone—Tachycardia—Docetaxel—breast cancer	1.15e-05	0.000197	CcSEcCtD
Dexamethasone—Feeling abnormal—Paclitaxel—breast cancer	1.15e-05	0.000196	CcSEcCtD
Dexamethasone—Oedema—Capecitabine—breast cancer	1.14e-05	0.000195	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—breast cancer	1.14e-05	0.000195	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Paclitaxel—breast cancer	1.14e-05	0.000195	CcSEcCtD
Dexamethasone—Diarrhoea—Gemcitabine—breast cancer	1.14e-05	0.000194	CcSEcCtD
Dexamethasone—Infection—Capecitabine—breast cancer	1.14e-05	0.000194	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—breast cancer	1.13e-05	0.000193	CcSEcCtD
Dexamethasone—Dizziness—Irinotecan—breast cancer	1.13e-05	0.000193	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—breast cancer	1.13e-05	0.000192	CcSEcCtD
Dexamethasone—Anorexia—Docetaxel—breast cancer	1.12e-05	0.000192	CcSEcCtD
Dexamethasone—Shock—Capecitabine—breast cancer	1.12e-05	0.000192	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—breast cancer	1.12e-05	0.000192	CcSEcCtD
Dexamethasone—Nervous system disorder—Capecitabine—breast cancer	1.12e-05	0.000192	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—breast cancer	1.12e-05	0.000191	CcSEcCtD
Dexamethasone—Eye disorder—Methotrexate—breast cancer	1.12e-05	0.000191	CcSEcCtD
Dexamethasone—Diarrhoea—Fluorouracil—breast cancer	1.12e-05	0.000191	CcSEcCtD
Dexamethasone—Thrombocytopenia—Capecitabine—breast cancer	1.12e-05	0.000191	CcSEcCtD
Dexamethasone—Tachycardia—Capecitabine—breast cancer	1.12e-05	0.000191	CcSEcCtD
Dexamethasone—Urticaria—Paclitaxel—breast cancer	1.11e-05	0.000189	CcSEcCtD
Dexamethasone—Hyperhidrosis—Capecitabine—breast cancer	1.1e-05	0.000189	CcSEcCtD
Dexamethasone—Hypotension—Docetaxel—breast cancer	1.1e-05	0.000188	CcSEcCtD
Dexamethasone—Prednisolone—ABCB1—breast cancer	1.1e-05	0.00866	CrCbGaD
Dexamethasone—Abdominal pain—Paclitaxel—breast cancer	1.1e-05	0.000188	CcSEcCtD
Dexamethasone—Body temperature increased—Paclitaxel—breast cancer	1.1e-05	0.000188	CcSEcCtD
Dexamethasone—Anorexia—Capecitabine—breast cancer	1.09e-05	0.000186	CcSEcCtD
Dexamethasone—Angiopathy—Methotrexate—breast cancer	1.09e-05	0.000186	CcSEcCtD
Dexamethasone—Vomiting—Mitoxantrone—breast cancer	1.09e-05	0.000186	CcSEcCtD
Dexamethasone—Vomiting—Irinotecan—breast cancer	1.09e-05	0.000186	CcSEcCtD
Dexamethasone—Dizziness—Fluorouracil—breast cancer	1.08e-05	0.000185	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—breast cancer	1.08e-05	0.000185	CcSEcCtD
Dexamethasone—Betamethasone—ABCB1—breast cancer	1.08e-05	0.00848	CrCbGaD
Dexamethasone—Rash—Irinotecan—breast cancer	1.08e-05	0.000184	CcSEcCtD
Dexamethasone—Rash—Mitoxantrone—breast cancer	1.08e-05	0.000184	CcSEcCtD
Dexamethasone—Dermatitis—Mitoxantrone—breast cancer	1.08e-05	0.000184	CcSEcCtD
Dexamethasone—Dermatitis—Irinotecan—breast cancer	1.08e-05	0.000184	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Docetaxel—breast cancer	1.08e-05	0.000184	CcSEcCtD
Dexamethasone—Headache—Mitoxantrone—breast cancer	1.07e-05	0.000183	CcSEcCtD
Dexamethasone—Headache—Irinotecan—breast cancer	1.07e-05	0.000183	CcSEcCtD
Dexamethasone—Hypotension—Capecitabine—breast cancer	1.07e-05	0.000182	CcSEcCtD
Dexamethasone—Insomnia—Docetaxel—breast cancer	1.07e-05	0.000182	CcSEcCtD
Dexamethasone—Paraesthesia—Docetaxel—breast cancer	1.06e-05	0.000181	CcSEcCtD
Dexamethasone—Alopecia—Methotrexate—breast cancer	1.06e-05	0.000181	CcSEcCtD
Dexamethasone—Vomiting—Gemcitabine—breast cancer	1.06e-05	0.000181	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—breast cancer	1.06e-05	0.00018	CcSEcCtD
Dexamethasone—Rash—Gemcitabine—breast cancer	1.05e-05	0.000179	CcSEcCtD
Dexamethasone—Dermatitis—Gemcitabine—breast cancer	1.05e-05	0.000179	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—breast cancer	1.05e-05	0.000179	CcSEcCtD
Dexamethasone—Erythema—Methotrexate—breast cancer	1.04e-05	0.000178	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—breast cancer	1.04e-05	0.000178	CcSEcCtD
Dexamethasone—Headache—Gemcitabine—breast cancer	1.04e-05	0.000178	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Capecitabine—breast cancer	1.04e-05	0.000178	CcSEcCtD
Dexamethasone—Vomiting—Fluorouracil—breast cancer	1.04e-05	0.000178	CcSEcCtD
Dexamethasone—Dyspepsia—Docetaxel—breast cancer	1.04e-05	0.000178	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—breast cancer	1.04e-05	0.000177	CcSEcCtD
Dexamethasone—Insomnia—Capecitabine—breast cancer	1.03e-05	0.000177	CcSEcCtD
Dexamethasone—Rash—Fluorouracil—breast cancer	1.03e-05	0.000176	CcSEcCtD
Dexamethasone—Dermatitis—Fluorouracil—breast cancer	1.03e-05	0.000176	CcSEcCtD
Dexamethasone—Paraesthesia—Capecitabine—breast cancer	1.03e-05	0.000175	CcSEcCtD
Dexamethasone—Decreased appetite—Docetaxel—breast cancer	1.03e-05	0.000175	CcSEcCtD
Dexamethasone—Headache—Fluorouracil—breast cancer	1.02e-05	0.000175	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Docetaxel—breast cancer	1.02e-05	0.000174	CcSEcCtD
Dexamethasone—Fatigue—Docetaxel—breast cancer	1.02e-05	0.000174	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—breast cancer	1.02e-05	0.000174	CcSEcCtD
Dexamethasone—Nausea—Mitoxantrone—breast cancer	1.01e-05	0.000173	CcSEcCtD
Dexamethasone—Nausea—Irinotecan—breast cancer	1.01e-05	0.000173	CcSEcCtD
Dexamethasone—Hydrocortisone—CYP3A4—breast cancer	1.01e-05	0.00796	CrCbGaD
Dexamethasone—Pain—Docetaxel—breast cancer	1.01e-05	0.000172	CcSEcCtD
Dexamethasone—Dyspepsia—Capecitabine—breast cancer	1.01e-05	0.000172	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—breast cancer	1e-05	0.000171	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—breast cancer	9.99e-06	0.000171	CcSEcCtD
Dexamethasone—Asthenia—Paclitaxel—breast cancer	9.99e-06	0.000171	CcSEcCtD
Dexamethasone—Decreased appetite—Capecitabine—breast cancer	9.93e-06	0.00017	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—breast cancer	9.9e-06	0.000169	CcSEcCtD
Dexamethasone—Nausea—Gemcitabine—breast cancer	9.88e-06	0.000169	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Capecitabine—breast cancer	9.86e-06	0.000169	CcSEcCtD
Dexamethasone—Fatigue—Capecitabine—breast cancer	9.85e-06	0.000168	CcSEcCtD
Dexamethasone—Pruritus—Paclitaxel—breast cancer	9.85e-06	0.000168	CcSEcCtD
Dexamethasone—Pain—Capecitabine—breast cancer	9.77e-06	0.000167	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—breast cancer	9.75e-06	0.000167	CcSEcCtD
Dexamethasone—Feeling abnormal—Docetaxel—breast cancer	9.73e-06	0.000166	CcSEcCtD
Dexamethasone—Nausea—Fluorouracil—breast cancer	9.71e-06	0.000166	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—breast cancer	9.69e-06	0.000166	CcSEcCtD
Dexamethasone—Ill-defined disorder—Methotrexate—breast cancer	9.67e-06	0.000165	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Docetaxel—breast cancer	9.65e-06	0.000165	CcSEcCtD
Dexamethasone—Diarrhoea—Paclitaxel—breast cancer	9.53e-06	0.000163	CcSEcCtD
Dexamethasone—Feeling abnormal—Capecitabine—breast cancer	9.42e-06	0.000161	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—breast cancer	9.41e-06	0.000161	CcSEcCtD
Dexamethasone—Malaise—Methotrexate—breast cancer	9.4e-06	0.000161	CcSEcCtD
Dexamethasone—Vertigo—Methotrexate—breast cancer	9.36e-06	0.00016	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Capecitabine—breast cancer	9.34e-06	0.00016	CcSEcCtD
Dexamethasone—Abdominal pain—Docetaxel—breast cancer	9.33e-06	0.000159	CcSEcCtD
Dexamethasone—Body temperature increased—Docetaxel—breast cancer	9.33e-06	0.000159	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—breast cancer	9.26e-06	0.000158	CcSEcCtD
Dexamethasone—Dizziness—Paclitaxel—breast cancer	9.21e-06	0.000157	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—breast cancer	9.16e-06	0.000157	CcSEcCtD
Dexamethasone—Urticaria—Capecitabine—breast cancer	9.08e-06	0.000155	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—breast cancer	9.05e-06	0.000155	CcSEcCtD
Dexamethasone—Body temperature increased—Capecitabine—breast cancer	9.03e-06	0.000154	CcSEcCtD
Dexamethasone—Abdominal pain—Capecitabine—breast cancer	9.03e-06	0.000154	CcSEcCtD
Dexamethasone—Convulsion—Methotrexate—breast cancer	9.03e-06	0.000154	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—breast cancer	9.02e-06	0.000154	CcSEcCtD
Dexamethasone—Myalgia—Methotrexate—breast cancer	8.87e-06	0.000152	CcSEcCtD
Dexamethasone—Vomiting—Paclitaxel—breast cancer	8.85e-06	0.000151	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—breast cancer	8.8e-06	0.00015	CcSEcCtD
Dexamethasone—Rash—Paclitaxel—breast cancer	8.78e-06	0.00015	CcSEcCtD
Dexamethasone—Dermatitis—Paclitaxel—breast cancer	8.77e-06	0.00015	CcSEcCtD
Dexamethasone—Discomfort—Methotrexate—breast cancer	8.77e-06	0.00015	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—breast cancer	8.76e-06	0.00015	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—breast cancer	8.75e-06	0.000149	CcSEcCtD
Dexamethasone—Headache—Paclitaxel—breast cancer	8.72e-06	0.000149	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—breast cancer	8.57e-06	0.000147	CcSEcCtD
Dexamethasone—Anaphylactic shock—Methotrexate—breast cancer	8.51e-06	0.000145	CcSEcCtD
Dexamethasone—Asthenia—Docetaxel—breast cancer	8.47e-06	0.000145	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—breast cancer	8.45e-06	0.000144	CcSEcCtD
Dexamethasone—Infection—Methotrexate—breast cancer	8.45e-06	0.000144	CcSEcCtD
Dexamethasone—Hydrocortisone—ABCB1—breast cancer	8.42e-06	0.00662	CrCbGaD
Dexamethasone—Hypertension—Epirubicin—breast cancer	8.42e-06	0.000144	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—breast cancer	8.37e-06	0.000143	CcSEcCtD
Dexamethasone—Pruritus—Docetaxel—breast cancer	8.35e-06	0.000143	CcSEcCtD
Dexamethasone—Nervous system disorder—Methotrexate—breast cancer	8.34e-06	0.000143	CcSEcCtD
Dexamethasone—Thrombocytopenia—Methotrexate—breast cancer	8.33e-06	0.000142	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—breast cancer	8.3e-06	0.000142	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—breast cancer	8.27e-06	0.000141	CcSEcCtD
Dexamethasone—Nausea—Paclitaxel—breast cancer	8.27e-06	0.000141	CcSEcCtD
Dexamethasone—Hyperhidrosis—Methotrexate—breast cancer	8.22e-06	0.000141	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—breast cancer	8.2e-06	0.00014	CcSEcCtD
Dexamethasone—Asthenia—Capecitabine—breast cancer	8.2e-06	0.00014	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—breast cancer	8.14e-06	0.000139	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—breast cancer	8.11e-06	0.000139	CcSEcCtD
Dexamethasone—Anorexia—Methotrexate—breast cancer	8.11e-06	0.000139	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—breast cancer	8.09e-06	0.000138	CcSEcCtD
Dexamethasone—Pruritus—Capecitabine—breast cancer	8.08e-06	0.000138	CcSEcCtD
Dexamethasone—Diarrhoea—Docetaxel—breast cancer	8.07e-06	0.000138	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—breast cancer	7.96e-06	0.000136	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—breast cancer	7.96e-06	0.000136	CcSEcCtD
Dexamethasone—Hypotension—Methotrexate—breast cancer	7.95e-06	0.000136	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—breast cancer	7.93e-06	0.000136	CcSEcCtD
Dexamethasone—Infection—Epirubicin—breast cancer	7.91e-06	0.000135	CcSEcCtD
Dexamethasone—Shock—Epirubicin—breast cancer	7.83e-06	0.000134	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—breast cancer	7.82e-06	0.000134	CcSEcCtD
Dexamethasone—Diarrhoea—Capecitabine—breast cancer	7.82e-06	0.000134	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—breast cancer	7.81e-06	0.000133	CcSEcCtD
Dexamethasone—Dizziness—Docetaxel—breast cancer	7.8e-06	0.000133	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—breast cancer	7.79e-06	0.000133	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—breast cancer	7.79e-06	0.000133	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—breast cancer	7.77e-06	0.000133	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Methotrexate—breast cancer	7.75e-06	0.000132	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—breast cancer	7.7e-06	0.000132	CcSEcCtD
Dexamethasone—Insomnia—Methotrexate—breast cancer	7.69e-06	0.000131	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—breast cancer	7.68e-06	0.000131	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—breast cancer	7.66e-06	0.000131	CcSEcCtD
Dexamethasone—Paraesthesia—Methotrexate—breast cancer	7.64e-06	0.000131	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—breast cancer	7.59e-06	0.00013	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—breast cancer	7.59e-06	0.00013	CcSEcCtD
Dexamethasone—Dizziness—Capecitabine—breast cancer	7.56e-06	0.000129	CcSEcCtD
Dexamethasone—Vomiting—Docetaxel—breast cancer	7.5e-06	0.000128	CcSEcCtD
Dexamethasone—Dyspepsia—Methotrexate—breast cancer	7.49e-06	0.000128	CcSEcCtD
Dexamethasone—Rash—Docetaxel—breast cancer	7.44e-06	0.000127	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—breast cancer	7.44e-06	0.000127	CcSEcCtD
Dexamethasone—Dermatitis—Docetaxel—breast cancer	7.43e-06	0.000127	CcSEcCtD
Dexamethasone—Decreased appetite—Methotrexate—breast cancer	7.39e-06	0.000126	CcSEcCtD
Dexamethasone—Headache—Docetaxel—breast cancer	7.39e-06	0.000126	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—breast cancer	7.37e-06	0.000126	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—breast cancer	7.37e-06	0.000126	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Methotrexate—breast cancer	7.34e-06	0.000126	CcSEcCtD
Dexamethasone—Fatigue—Methotrexate—breast cancer	7.33e-06	0.000125	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—breast cancer	7.32e-06	0.000125	CcSEcCtD
Dexamethasone—Pain—Methotrexate—breast cancer	7.27e-06	0.000124	CcSEcCtD
Dexamethasone—Vomiting—Capecitabine—breast cancer	7.26e-06	0.000124	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—breast cancer	7.25e-06	0.000124	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—breast cancer	7.25e-06	0.000124	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—breast cancer	7.22e-06	0.000123	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—breast cancer	7.21e-06	0.000123	CcSEcCtD
Dexamethasone—Rash—Capecitabine—breast cancer	7.2e-06	0.000123	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—breast cancer	7.2e-06	0.000123	CcSEcCtD
Dexamethasone—Dermatitis—Capecitabine—breast cancer	7.2e-06	0.000123	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—breast cancer	7.19e-06	0.000123	CcSEcCtD
Dexamethasone—Headache—Capecitabine—breast cancer	7.16e-06	0.000122	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—breast cancer	7.15e-06	0.000122	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—breast cancer	7.12e-06	0.000122	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—breast cancer	7.02e-06	0.00012	CcSEcCtD
Dexamethasone—Nausea—Docetaxel—breast cancer	7.01e-06	0.00012	CcSEcCtD
Dexamethasone—Feeling abnormal—Methotrexate—breast cancer	7.01e-06	0.00012	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—breast cancer	7.01e-06	0.00012	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Methotrexate—breast cancer	6.96e-06	0.000119	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—breast cancer	6.92e-06	0.000118	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—breast cancer	6.88e-06	0.000118	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—breast cancer	6.87e-06	0.000117	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—breast cancer	6.86e-06	0.000117	CcSEcCtD
Dexamethasone—Pain—Epirubicin—breast cancer	6.81e-06	0.000116	CcSEcCtD
Dexamethasone—Nausea—Capecitabine—breast cancer	6.79e-06	0.000116	CcSEcCtD
Dexamethasone—Urticaria—Methotrexate—breast cancer	6.76e-06	0.000115	CcSEcCtD
Dexamethasone—Abdominal pain—Methotrexate—breast cancer	6.72e-06	0.000115	CcSEcCtD
Dexamethasone—Body temperature increased—Methotrexate—breast cancer	6.72e-06	0.000115	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.71e-06	0.000115	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—breast cancer	6.66e-06	0.000114	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—breast cancer	6.61e-06	0.000113	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—breast cancer	6.56e-06	0.000112	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—breast cancer	6.51e-06	0.000111	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—breast cancer	6.48e-06	0.000111	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—breast cancer	6.4e-06	0.000109	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—breast cancer	6.36e-06	0.000109	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—breast cancer	6.35e-06	0.000109	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—breast cancer	6.32e-06	0.000108	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—breast cancer	6.3e-06	0.000108	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—breast cancer	6.29e-06	0.000108	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—breast cancer	6.29e-06	0.000108	CcSEcCtD
Dexamethasone—Asthenia—Methotrexate—breast cancer	6.1e-06	0.000104	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—breast cancer	6.07e-06	0.000104	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—breast cancer	6.02e-06	0.000103	CcSEcCtD
Dexamethasone—Pruritus—Methotrexate—breast cancer	6.02e-06	0.000103	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—breast cancer	5.85e-06	0.0001	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—breast cancer	5.82e-06	9.95e-05	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—breast cancer	5.82e-06	9.95e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Methotrexate—breast cancer	5.82e-06	9.95e-05	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—breast cancer	5.71e-06	9.76e-05	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—breast cancer	5.63e-06	9.63e-05	CcSEcCtD
Dexamethasone—Dizziness—Methotrexate—breast cancer	5.62e-06	9.61e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—breast cancer	5.45e-06	9.31e-05	CcSEcCtD
Dexamethasone—Vomiting—Methotrexate—breast cancer	5.41e-06	9.24e-05	CcSEcCtD
Dexamethasone—Rash—Methotrexate—breast cancer	5.36e-06	9.17e-05	CcSEcCtD
Dexamethasone—Dermatitis—Methotrexate—breast cancer	5.36e-06	9.16e-05	CcSEcCtD
Dexamethasone—Headache—Methotrexate—breast cancer	5.33e-06	9.11e-05	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—breast cancer	5.28e-06	9.03e-05	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—breast cancer	5.26e-06	9e-05	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—breast cancer	5.21e-06	8.91e-05	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—breast cancer	5.06e-06	8.65e-05	CcSEcCtD
Dexamethasone—Nausea—Methotrexate—breast cancer	5.05e-06	8.64e-05	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—breast cancer	5.04e-06	8.61e-05	CcSEcCtD
Dexamethasone—Rash—Epirubicin—breast cancer	5.02e-06	8.58e-05	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—breast cancer	5.01e-06	8.57e-05	CcSEcCtD
Dexamethasone—Headache—Epirubicin—breast cancer	4.99e-06	8.52e-05	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—breast cancer	4.87e-06	8.32e-05	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—breast cancer	4.73e-06	8.08e-05	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—breast cancer	4.68e-06	8e-05	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—breast cancer	4.64e-06	7.94e-05	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—breast cancer	4.64e-06	7.93e-05	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—breast cancer	4.61e-06	7.89e-05	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—breast cancer	4.37e-06	7.48e-05	CcSEcCtD
Dexamethasone—ABCG2—Metabolism—PIK3CB—breast cancer	3.62e-07	6.71e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CG—breast cancer	3.61e-07	6.68e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA3—breast cancer	3.6e-07	6.67e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CB—breast cancer	3.59e-07	6.65e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTGS2—breast cancer	3.59e-07	6.65e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NOS3—breast cancer	3.58e-07	6.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC2A2—breast cancer	3.57e-07	6.62e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PTEN—breast cancer	3.57e-07	6.62e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TYMS—breast cancer	3.57e-07	6.61e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—NOS3—breast cancer	3.57e-07	6.61e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTGS2—breast cancer	3.56e-07	6.59e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.55e-07	6.58e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—COMT—breast cancer	3.55e-07	6.57e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTP1—breast cancer	3.53e-07	6.54e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PLA2G4A—breast cancer	3.53e-07	6.54e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NCOR1—breast cancer	3.53e-07	6.54e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GSTM1—breast cancer	3.53e-07	6.54e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—COMT—breast cancer	3.52e-07	6.52e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CAV1—breast cancer	3.51e-07	6.51e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CPT1A—breast cancer	3.5e-07	6.49e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTR—breast cancer	3.5e-07	6.49e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCG2—breast cancer	3.5e-07	6.49e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KRAS—breast cancer	3.5e-07	6.48e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTP1—breast cancer	3.5e-07	6.48e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—MTHFR—breast cancer	3.49e-07	6.47e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TYMS—breast cancer	3.48e-07	6.45e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HMOX1—breast cancer	3.48e-07	6.45e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ITPR1—breast cancer	3.48e-07	6.44e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CG—breast cancer	3.47e-07	6.42e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MAPK3—breast cancer	3.46e-07	6.41e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HMOX1—breast cancer	3.45e-07	6.4e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ITPR1—breast cancer	3.45e-07	6.38e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PLA2G4A—breast cancer	3.44e-07	6.38e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NCOR1—breast cancer	3.44e-07	6.38e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GSTM1—breast cancer	3.44e-07	6.38e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PTEN—breast cancer	3.44e-07	6.38e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HPGDS—breast cancer	3.43e-07	6.36e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HBA1—breast cancer	3.41e-07	6.32e-06	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—breast cancer	3.4e-07	6.3e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CG—breast cancer	3.4e-07	6.29e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MDM2—breast cancer	3.39e-07	6.28e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CG—breast cancer	3.39e-07	6.28e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RAF1—breast cancer	3.38e-07	6.26e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GPX1—breast cancer	3.38e-07	6.26e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—breast cancer	3.37e-07	6.24e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.36e-07	6.22e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CYP1A1—breast cancer	3.34e-07	6.2e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—breast cancer	3.34e-07	6.2e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—breast cancer	3.34e-07	6.19e-06	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—PIK3CA—breast cancer	3.34e-07	6.19e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ACHE—breast cancer	3.33e-07	6.17e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTT1—breast cancer	3.33e-07	6.17e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ERCC2—breast cancer	3.32e-07	6.14e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—breast cancer	3.31e-07	6.14e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CB—breast cancer	3.3e-07	6.11e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MTOR—breast cancer	3.3e-07	6.11e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GPX1—breast cancer	3.3e-07	6.11e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CD4—breast cancer	3.29e-07	6.1e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CB—breast cancer	3.29e-07	6.1e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TYMS—breast cancer	3.28e-07	6.08e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CYP1A1—breast cancer	3.26e-07	6.05e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTGS2—breast cancer	3.26e-07	6.04e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TYMS—breast cancer	3.25e-07	6.03e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.25e-07	6.01e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GSTM1—breast cancer	3.25e-07	6.01e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NCOR1—breast cancer	3.25e-07	6.01e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ERCC2—breast cancer	3.24e-07	6e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CAV1—breast cancer	3.22e-07	5.97e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NCOR1—breast cancer	3.22e-07	5.96e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.22e-07	5.96e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GSTM1—breast cancer	3.22e-07	5.96e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PIK3CA—breast cancer	3.22e-07	5.96e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CG—breast cancer	3.2e-07	5.93e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CD—breast cancer	3.17e-07	5.87e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP17A1—breast cancer	3.15e-07	5.84e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PTEN—breast cancer	3.13e-07	5.8e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ALB—breast cancer	3.13e-07	5.8e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO1—breast cancer	3.12e-07	5.78e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS1—breast cancer	3.12e-07	5.78e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—MTHFR—breast cancer	3.12e-07	5.78e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—breast cancer	3.11e-07	5.76e-06	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—breast cancer	3.11e-07	5.76e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GPX1—breast cancer	3.11e-07	5.76e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PTEN—breast cancer	3.1e-07	5.75e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1B—breast cancer	3.1e-07	5.74e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GPX1—breast cancer	3.08e-07	5.71e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.08e-07	5.7e-06	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—breast cancer	3.08e-07	5.7e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CYP1A1—breast cancer	3.08e-07	5.7e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP2D6—breast cancer	3.06e-07	5.67e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ERCC2—breast cancer	3.05e-07	5.65e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CYP1A1—breast cancer	3.05e-07	5.65e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CD—breast cancer	3.05e-07	5.65e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—MTHFR—breast cancer	3.04e-07	5.64e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ERCC2—breast cancer	3.02e-07	5.6e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ALB—breast cancer	3.01e-07	5.57e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA2—breast cancer	3e-07	5.57e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NOS3—breast cancer	2.99e-07	5.55e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CD—breast cancer	2.99e-07	5.53e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CD—breast cancer	2.98e-07	5.52e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—breast cancer	2.98e-07	5.51e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ALB—breast cancer	2.95e-07	5.46e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ALB—breast cancer	2.94e-07	5.45e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CG—breast cancer	2.94e-07	5.44e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CTNNB1—breast cancer	2.93e-07	5.42e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—FASN—breast cancer	2.91e-07	5.4e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—BCHE—breast cancer	2.9e-07	5.38e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NOS3—breast cancer	2.88e-07	5.33e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CAV1—breast cancer	2.88e-07	5.33e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—MTHFR—breast cancer	2.87e-07	5.31e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC5A5—breast cancer	2.87e-07	5.31e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—CDKN1A—breast cancer	2.86e-07	5.29e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTEN—breast cancer	2.85e-07	5.28e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—IL6—breast cancer	2.85e-07	5.28e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PTEN—breast cancer	2.85e-07	5.27e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—MTHFR—breast cancer	2.84e-07	5.27e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NOS3—breast cancer	2.82e-07	5.22e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CD—breast cancer	2.81e-07	5.21e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NOS3—breast cancer	2.81e-07	5.21e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CAV1—breast cancer	2.81e-07	5.2e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—PIK3CA—breast cancer	2.79e-07	5.17e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ALB—breast cancer	2.78e-07	5.15e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC2A1—breast cancer	2.77e-07	5.13e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NQO1—breast cancer	2.77e-07	5.13e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CB—breast cancer	2.76e-07	5.12e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.75e-07	5.09e-06	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—breast cancer	2.73e-07	5.06e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NOS3—breast cancer	2.66e-07	4.92e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CB—breast cancer	2.66e-07	4.92e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1B1—breast cancer	2.65e-07	4.92e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CAV1—breast cancer	2.65e-07	4.9e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SRC—breast cancer	2.65e-07	4.9e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTGS2—breast cancer	2.63e-07	4.88e-06	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—breast cancer	2.63e-07	4.87e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CAV1—breast cancer	2.62e-07	4.86e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CG—breast cancer	2.62e-07	4.85e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.6e-07	4.82e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CB—breast cancer	2.6e-07	4.82e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CB—breast cancer	2.6e-07	4.81e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CD—breast cancer	2.58e-07	4.78e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTGS2—breast cancer	2.58e-07	4.78e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTGS2—breast cancer	2.57e-07	4.77e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CG—breast cancer	2.56e-07	4.74e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—STAT3—breast cancer	2.55e-07	4.72e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ALB—breast cancer	2.55e-07	4.72e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOA1—breast cancer	2.53e-07	4.69e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—PIK3CA—breast cancer	2.52e-07	4.67e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.51e-07	4.64e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP19A1—breast cancer	2.5e-07	4.62e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—STK11—breast cancer	2.5e-07	4.62e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CB—breast cancer	2.45e-07	4.54e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MAPK3—breast cancer	2.44e-07	4.51e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NOS3—breast cancer	2.44e-07	4.51e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTGS2—breast cancer	2.43e-07	4.5e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—PIK3CA—breast cancer	2.43e-07	4.5e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CG—breast cancer	2.41e-07	4.46e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CG—breast cancer	2.39e-07	4.42e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PTEN—breast cancer	2.39e-07	4.42e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—breast cancer	2.37e-07	4.39e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—TGFB1—breast cancer	2.36e-07	4.38e-06	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—breast cancer	2.34e-07	4.33e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—COMT—breast cancer	2.32e-07	4.3e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—breast cancer	2.32e-07	4.29e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTP1—breast cancer	2.31e-07	4.28e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CD—breast cancer	2.3e-07	4.27e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PTEN—breast cancer	2.3e-07	4.25e-06	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—breast cancer	2.28e-07	4.22e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HMOX1—breast cancer	2.28e-07	4.22e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ALB—breast cancer	2.27e-07	4.21e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ITPR1—breast cancer	2.27e-07	4.21e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CB—breast cancer	2.25e-07	4.17e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PTEN—breast cancer	2.25e-07	4.16e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CD—breast cancer	2.25e-07	4.16e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PTEN—breast cancer	2.24e-07	4.16e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTGS2—breast cancer	2.23e-07	4.13e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ALB—breast cancer	2.22e-07	4.11e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—PIK3CA—breast cancer	2.21e-07	4.09e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—KRAS—breast cancer	2.19e-07	4.06e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—PIK3CA—breast cancer	2.19e-07	4.06e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—breast cancer	2.19e-07	4.05e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NOS3—breast cancer	2.17e-07	4.03e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TYMS—breast cancer	2.15e-07	3.98e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NOS3—breast cancer	2.12e-07	3.93e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.12e-07	3.93e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GSTM1—breast cancer	2.12e-07	3.93e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NCOR1—breast cancer	2.12e-07	3.93e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PTEN—breast cancer	2.12e-07	3.93e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CD—breast cancer	2.12e-07	3.92e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CD—breast cancer	2.1e-07	3.89e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ALB—breast cancer	2.09e-07	3.87e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ALB—breast cancer	2.07e-07	3.84e-06	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—breast cancer	2.06e-07	3.82e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GPX1—breast cancer	2.03e-07	3.76e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PIK3CA—breast cancer	2.01e-07	3.73e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CYP1A1—breast cancer	2.01e-07	3.73e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CB—breast cancer	2.01e-07	3.72e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—PIK3CA—breast cancer	2.01e-07	3.72e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NOS3—breast cancer	2e-07	3.71e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ERCC2—breast cancer	1.99e-07	3.7e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTGS2—breast cancer	1.99e-07	3.68e-06	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—breast cancer	1.98e-07	3.67e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NOS3—breast cancer	1.98e-07	3.67e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CB—breast cancer	1.96e-07	3.63e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PTEN—breast cancer	1.94e-07	3.6e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTGS2—breast cancer	1.94e-07	3.6e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—MTHFR—breast cancer	1.88e-07	3.47e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—breast cancer	1.86e-07	3.45e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.85e-07	3.42e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CB—breast cancer	1.83e-07	3.39e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTGS2—breast cancer	1.83e-07	3.39e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTGS2—breast cancer	1.81e-07	3.36e-06	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—breast cancer	1.8e-07	3.34e-06	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—breast cancer	1.79e-07	3.31e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—IL6—breast cancer	1.78e-07	3.3e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PTEN—breast cancer	1.73e-07	3.21e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CAV1—breast cancer	1.73e-07	3.2e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PTEN—breast cancer	1.69e-07	3.14e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—PIK3CA—breast cancer	1.69e-07	3.12e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—breast cancer	1.64e-07	3.04e-06	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—breast cancer	1.64e-07	3.04e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—PIK3CA—breast cancer	1.62e-07	3e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PTEN—breast cancer	1.6e-07	2.96e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—PIK3CA—breast cancer	1.59e-07	2.94e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—PIK3CA—breast cancer	1.58e-07	2.93e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PTEN—breast cancer	1.58e-07	2.93e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.58e-07	2.92e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—PIK3CA—breast cancer	1.5e-07	2.77e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CD—breast cancer	1.39e-07	2.57e-06	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—breast cancer	1.38e-07	2.55e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—PIK3CA—breast cancer	1.37e-07	2.54e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ALB—breast cancer	1.37e-07	2.53e-06	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—breast cancer	1.32e-07	2.45e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NOS3—breast cancer	1.31e-07	2.42e-06	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—breast cancer	1.3e-07	2.4e-06	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—breast cancer	1.29e-07	2.4e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—PIK3CA—breast cancer	1.22e-07	2.27e-06	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—breast cancer	1.22e-07	2.26e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CB—breast cancer	1.21e-07	2.24e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTGS2—breast cancer	1.2e-07	2.22e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—PIK3CA—breast cancer	1.19e-07	2.21e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—PIK3CA—breast cancer	1.13e-07	2.08e-06	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—breast cancer	1.12e-07	2.07e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—PIK3CA—breast cancer	1.12e-07	2.07e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PTEN—breast cancer	1.04e-07	1.93e-06	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—breast cancer	1e-07	1.85e-06	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—breast cancer	9.76e-08	1.81e-06	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—breast cancer	9.2e-08	1.7e-06	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—breast cancer	9.12e-08	1.69e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PIK3CA—breast cancer	7.36e-08	1.36e-06	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—breast cancer	6.01e-08	1.11e-06	CbGpPWpGaD
